Brain scanning study in ex-smokers and quitting smokers – participants wanted

The Division of Brain Sciences, Imperial College London at the Hammersmith Hospital, London is studying how the brain and hormones control eating and addictive behaviours in the GHADD study.

Volunteers will have functional magnetic resonance imaging (fMRI) brain scans, and an infusion of 2 different hormones to see how the brain responds.

The hormones have been safely administered in many previous studies.

There is a health screening visit, followed by 3 study visits.

To take part you must be aged 18 to 60 years old, have given up smoking cigarettes within the last year, or be just about to give up smoking cigarettes or vaping e-cigarettes.

You will NOT be able to take part if you:

  • are vegetarian, vegan, gluten or lactose intolerant
  • have a pacemaker, or some types of metal implants and clips
  • are claustrophobic, pregnant or breast feeding

You will be paid expenses including travel costs.

Please check our quick online screening tool on www.ghadd.co.uk to see if you may be eligible

If interested, please contact us at: 020 7594 6648 or ghadd@imperial.ac.uk

Approved by Local Ethics Research Committee (REC 15/LO/1041)

NIHR Clinical Research Network helps to recruit first global patient in surgical research study

From L-R: Mr Naim Fakih, Donna McLean, Fatima Akbar, Mr Ahmed Ahmed, and Mr Christos Tsiornis
From L-R: Mr Naim Fakih, Donna McLean, Fatima Akbar, Mr Ahmed Ahmed, and Mr Christos Tsiornis

The NIHR Clinical Research Network, which supports researchers and clinicians across Imperial College and Imperial College Healthcare NHS Trust, have helped recruit the first global patient into a surgical study. The trial, which is being conducted by Mr Ahmed Ahmed, Clinical Senior Lecturer in Bariatric Surgery, will compare types of surgical stapler, to investigate whether a newer device will be more efficient and reduce complications for patients.

For more information on the Clinical Research Network and how they can help you, visit their website, follow them at @nihrcrn_nwldn or email kate.wighton@nihr.ac.uk.

Kate Wighton
Communications Manager
NIHR Clinical Research Network (North West London)

Healthy volunteers wanted for ‘Genetic Studies of the Heart and Circulation’ study

We are looking for healthy volunteers to part in an Imperial sponsored study called ‘Genetic Studies of the Heart and Circulation’, which aims to develop an atlas of the human heart to help scientists to determine the effect of different DNA and genes on heart shape and function. The research has been given ethical approval by the Research Ethics Committee (approval reference number 09/H0707/69).

Volunteers must be registered with a UK GP, have no heart-related health problems, and must be between the ages of 18 and 80. The study will involve some general lifestyle questions; height, weight and simple heart test function measurements; a three dimensional heart scan; and a blood (or saliva) sample. The appointment may take up to 90 minutes, and are held at Hammersmith Hospital, Du Cane Road, W12.

All participants will be reimbursed £25 and will receive a free CD of their scan.

To request further information email the Research Nurses at heart@imperial.nhs.uk

Laura Monje Garcia
Research Nurse, Cardiology
Robert Steiner MRI Unit
Hammersmith Hospital

Healthy Volunteers for HIV Vaccine Trials Wanted

cuthivacThe Clinical Trials Centre at St. Mary’s Hospital are looking for healthy HIV NEGATIVE male and female volunteers between the ages of 18-45, who are going to be around London for 6 months to take part in a Phase I clinical trial to develop a new vaccine.

If you are interested in wanting to take part please contact Stephen on free phone 0800 358 3001 or email: hivvaccinetrial@imperial.ac.uk for more information.  Your time and travel for all visits will be reimbursed and you’ll receive up to £1100 over the course of the study.

This trial, led by Professor Robin Shattock in the Department of Medicine, forms part of the EU funded CUT’HIVAC project, which aims at assessing a new HIV vaccine strategy to prevent and control HIV infection based on transcutaneous and/or mucosal needle-free vaccination.

Study approved by Cambridge East Research Ethics Committee.